Use of Probiotics to Reduce Infections, Death and ESBL Colonisation

PHASE3CompletedINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

July 10, 2023

Study Completion Date

September 19, 2023

Conditions
Neonatal Sepsis
Interventions
BIOLOGICAL

Labinic (R) probiotic mixture

Labinic (R) probiotic mixture containing Lactobacillus acidophilus and Bifidobacterium infantis and B. breve

OTHER

Placebo

Placebo mixture

Trial Locations (1)

Unknown

Haydom Lutheran Hospital, Babati

All Listed Sponsors
collaborator

University of Bergen

OTHER

collaborator

Helse Stavanger HF

OTHER_GOV

collaborator

UiT The Arctic University of Norway

OTHER

collaborator

Muhimbili University of Health and Allied Sciences

OTHER

lead

Haydom Lutheran Hospital

OTHER